Dr. Michelle Teng (WE ACE 2020) co-founds SynaptixBio
- Iwan Roberts
- Oct 7, 2021
- 1 min read
Updated: Feb 9, 2022
14 October 2021
Dr. Michelle Teng (WE ACE Cohort: 2020) co-founded SynaptixBio to develop novel lifesaving therapies for pediatric leukodystrophies. She serves as a co-founder, CSO, and Executive Director of the company.
Click on their website below to learn more.
Comments